Compile Data Set for Download or QSAR
maximum 50k data
Found 93 with Last Name = 'freedman' and Initial = 'jm'
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM20461((6E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methy...)
Affinity DataKi:  6nMAssay Description:Binding affinity to human recombinant TRPV1More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50052442((4-Hydroxy-3-methoxy-phenyl)-acetic acid (2R,3S,3a...)
Affinity DataKi:  14nMAssay Description:Binding affinity to human recombinant TRPV1More data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196190(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi:  25nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196191(4-[4-iodo-2-[(5-quinoxalinylsulfonyl)amino]benzoyl...)
Affinity DataKi:  32nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196157(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi:  40nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478086(CHEMBL261682)
Affinity DataKi:  63nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478090(CHEMBL259762)
Affinity DataKi:  79nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478094(CHEMBL408452)
Affinity DataKi:  501nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478089(CHEMBL261636)
Affinity DataKi:  794nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478092(CHEMBL410708)
Affinity DataKi:  794nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196192(1-[4-bromo-2-[(quinolin-5-ylsulfonyl)amino]-benzoy...)
Affinity DataKi:  794nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478085(CHEMBL259224)
Affinity DataKi:  1.59E+3nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196171(1-[2-[(2,1,3-benzooxadiazol-4-ylsulfonyl)amino]-4-...)
Affinity DataKi:  1.59E+3nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478091(CHEMBL259751)
Affinity DataKi:  2.00E+3nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478087(CHEMBL409479)
Affinity DataKi:  3.16E+3nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478093(CHEMBL410905)
Affinity DataKi:  5.01E+3nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478088(CHEMBL412282)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478090(CHEMBL259762)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478093(CHEMBL410905)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478094(CHEMBL408452)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196152(1-[4-chloro-2-[(quinolin-8-ylsulfonyl)amino]-benzo...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196191(4-[4-iodo-2-[(5-quinoxalinylsulfonyl)amino]benzoyl...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478091(CHEMBL259751)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196190(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196157(1-[2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-4...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196160(1-[4-bromo-2-[(isoquinolin-5-ylsulfonyl)amino]-ben...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478092(CHEMBL410708)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478088(CHEMBL412282)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196172(1-[4-bromo-2-[[naphthalen-1-ylsulfonyl]amino]benzo...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196152(1-[4-chloro-2-[(quinolin-8-ylsulfonyl)amino]-benzo...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196160(1-[4-bromo-2-[(isoquinolin-5-ylsulfonyl)amino]-ben...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK2RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478089(CHEMBL261636)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196171(1-[2-[(2,1,3-benzooxadiazol-4-ylsulfonyl)amino]-4-...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478087(CHEMBL409479)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478086(CHEMBL261682)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196192(1-[4-bromo-2-[(quinolin-5-ylsulfonyl)amino]-benzoy...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50478085(CHEMBL259224)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50196172(1-[4-bromo-2-[[naphthalen-1-ylsulfonyl]amino]benzo...)
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]CCK8S from human CCK1RMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50331116(2-morpholino-N-(4-(trifluoromethyl)phenyl)-7-(3-(t...)
Affinity DataIC50:  6nMAssay Description:Antagonist activity at human recombinant TRPV1 assessed as inhibition of capsaicin-induced in intracellular calcium levels by cell-based FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50331150(CHEMBL1290369 | N-(4-tert-butylphenyl)-7-(3-(trifl...)
Affinity DataIC50:  9nMAssay Description:Antagonist activity at human recombinant TRPV1 assessed as inhibition of capsaicin-induced in intracellular calcium levels by cell-based FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50254114(CHEMBL461658 | N-(4-(trifluoromethyl)phenyl)-7-(3-...)
Affinity DataIC50:  15nMAssay Description:Antagonist activity at human recombinant TRPV1 assessed as inhibition of capsaicin-induced in intracellular calcium levels by cell-based FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50331131(2-methyl-2-(4-(2-(piperidin-1-yl)-7-(3-(trifluorom...)
Affinity DataIC50:  18nMAssay Description:Antagonist activity at human recombinant TRPV1 assessed as inhibition of capsaicin-induced in intracellular calcium levels by cell-based FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50331154(CHEMBL1290584 | N-(4-tert-butylphenyl)-2-isopropyl...)
Affinity DataIC50:  18nMAssay Description:Antagonist activity at human recombinant TRPV1 assessed as inhibition of capsaicin-induced in intracellular calcium levels by cell-based FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM20461((6E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methy...)
Affinity DataIC50:  19nMAssay Description:Binding affinity to rat TRPV1More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50331117(2-thiomorpholino-N-(4-(trifluoromethyl)phenyl)-7-(...)
Affinity DataIC50:  19nMAssay Description:Antagonist activity at human recombinant TRPV1 assessed as inhibition of capsaicin-induced in intracellular calcium levels by cell-based FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50331124(2-(piperidin-1-yl)-N-(5-(trifluoromethyl)pyrazin-2...)
Affinity DataIC50:  21nMAssay Description:Antagonist activity at human recombinant TRPV1 assessed as inhibition of capsaicin-induced in intracellular calcium levels by cell-based FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50331157(CHEMBL1290704 | N-(4-tert-butylphenyl)-7-(3-(trifl...)
Affinity DataIC50:  25nMAssay Description:Antagonist activity at human recombinant TRPV1 assessed as inhibition of capsaicin-induced in intracellular calcium levels by cell-based FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50331137(CHEMBL1289818 | N,N-dimethyl-4-(2-(piperidin-1-yl)...)
Affinity DataIC50:  25nMAssay Description:Antagonist activity at human recombinant TRPV1 assessed as inhibition of capsaicin-induced in intracellular calcium levels by cell-based FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50331160(2-cyclopropyl-N-(4-(trifluoromethyl)phenyl)-7-(3-(...)
Affinity DataIC50:  31nMAssay Description:Antagonist activity at human recombinant TRPV1 assessed as inhibition of capsaicin-induced in intracellular calcium levels by cell-based FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50331111(2-phenyl-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifl...)
Affinity DataIC50:  37nMAssay Description:Antagonist activity at human recombinant TRPV1 assessed as inhibition of capsaicin-induced in intracellular calcium levels by cell-based FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 93 total ) | Next | Last >>
Jump to: